Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentuximab + Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer
NCT04053205Phase 2Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Nov 2019
- Primary completion
- Jun 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of gentuximab in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Nov 2019; status: completed.
02
Drugs
gentuximab
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT04053205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04053205.